# Swedish Orphan Biovitrum (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/swedish-orphan-biovitrum-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 27 |
| Citations | 24,070 |
| City | Waltham |
| Country | US |
| Description | Swedish Orphan Biovitrum (United States) is a research organisation in Waltham, US. OpenAlex records 81 works and 24,070 citations for it. |
| Homepage | https://www.sobi.com/en/taxonomy/term/19 |
| OpenAlex ID | https://openalex.org/I4210114803 |
| Region | Massachusetts |
| ROR ID | https://ror.org/01e5m5282 |
| Type | company |
| Works | 81 |

## University papers

- [Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors](https://scholariq.org/papers/phase-i-and-pharmacokinetic-study-of-ecteinascidin-743-a-new-marine-compound/)
- [Erythema nodosum: Etiologic and predictive factors in a defined population](https://scholariq.org/papers/erythema-nodosum-etiologic-and-predictive-factors-in-a-defined-population/)
- [Phase I and Pharmacokinetic Study of Aplidine, a New Marine Cyclodepsipeptide in Patients With Advanced Malignancies](https://scholariq.org/papers/phase-i-and-pharmacokinetic-study-of-aplidine-a-new-marine-cyclodepsipeptide-in/)
- [Yondelis® (trabectedin, ET-743): the development of an anticancer agent of marine origin](https://scholariq.org/papers/yondelis-trabectedin-et-743-the-development-of-an-anticancer-agent-of-marine/)
- [Phase I Clinical and Pharmacokinetic Study of Kahalalide F in Patients with Advanced Androgen Refractory Prostate Cancer](https://scholariq.org/papers/phase-i-clinical-and-pharmacokinetic-study-of-kahalalide-f-in-patients-with/)
- [A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignancies.](https://scholariq.org/papers/a-phase-i-and-pharmacokinetic-study-of-ecteinascidin-743-on-a-daily-x-5-schedule/)
- [Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study.](https://scholariq.org/papers/pharmacokinetics-and-pharmacodynamics-of-the-novel-marine-derived-anticancer/)
- [Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat.](https://scholariq.org/papers/complete-protection-by-high-dose-dexamethasone-against-the-hepatotoxicity-of-the/)
- [Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity](https://scholariq.org/papers/pharmacokinetics-of-ecteinascidin-743-administered-as-a-24-h-continuous/)
- [Drug associated cutaneous vasculitis in adults in northwestern Spain.](https://scholariq.org/papers/drug-associated-cutaneous-vasculitis-in-adults-in-northwestern-spain/)
- [Clinical Presentation, Treatment Patterns, Burden of Disease, and the Association of Proteinuria with Clinical Outcomes in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative Glomerulonephritis: A Systematic Review](https://scholariq.org/papers/clinical-presentation-treatment-patterns-burden-of-disease-and-the-association/)

## University researchers

- [Luis López Lázaro](https://scholariq.org/researchers/luis-lopez-lazaro/)

## University top topics

Showing 8 of 25.

- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)
- [Neonatal Respiratory Health Research](https://scholariq.org/topics/neonatal-respiratory-health-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Reproductive Biology and Fertility](https://scholariq.org/topics/reproductive-biology-and-fertility/)
- [Blood transfusion and management](https://scholariq.org/topics/blood-transfusion-and-management/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.